{"id":10909,"date":"2025-03-05T10:20:14","date_gmt":"2025-03-05T09:20:14","guid":{"rendered":"https:\/\/www.aieop.org\/web\/?p=10909"},"modified":"2025-03-05T10:20:14","modified_gmt":"2025-03-05T09:20:14","slug":"survey-aieop-su-ototossicita-da-cisplatino-ed-uso-sts-come-strategia-di-otoprotezione","status":"publish","type":"post","link":"https:\/\/www.aieop.org\/web\/survey-aieop-su-ototossicita-da-cisplatino-ed-uso-sts-come-strategia-di-otoprotezione\/","title":{"rendered":"Survey AIEOP su ototossicit\u00e0 da cisplatino ed uso STS come strategia di otoprotezione"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 blog-article nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-right:120px;--awb-padding-left:120px;--awb-margin-top:60px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"--awb-bg-size:cover;--awb-margin-bottom:0px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-title title fusion-title-1 fusion-title-text fusion-title-size-two\"><h2 class=\"fusion-title-heading title-heading-left\" style=\"margin:0;\">Survey AIEOP su ototossicit\u00e0 da cisplatino ed uso STS come strategia di otoprotezione<\/h2><span class=\"awb-title-spacer\"><\/span><div class=\"title-sep-container\"><div class=\"title-sep sep-double sep-solid\" style=\"border-color:#e0dede;\"><\/div><\/div><\/div><div class=\"fusion-text fusion-text-1\"><p><span style=\"font-family: verdana, sans-serif;\">A tutti i colleghi dei Centri AIEOP,<\/span><\/p>\n<p><span style=\"font-family: verdana, sans-serif;\">a nome del GDL nuovi farmaci, e con il contributo del GDL effetti tardivi, Vi invitiamo a partecipare a questa breve<em>\u00a0survey\u00a0<\/em>sull&#8217;uso del Sodio Tiosolfato (STS) come agente protettivo dell&#8217;ipoacusia da cisplatino (CIHL) nei tumori solidi pediatrici, tra cui epatoblastoma, altri tumori solidi e neoplasie del sistema nervoso centrale (SNC).<\/span><\/p>\n<p><span style=\"font-family: verdana, sans-serif;\">Grazie al vostro contributo avremo la possibilit\u00e0 di comprendere in modo pi\u00f9 approfondito l&#8217;uso reale di tali strategie nei centri AIEOP gettando le basi per la creazione di un gruppo di lavoro\u00a0multidisciplinare che abbia il compito di valutare le attuali opzioni terapeutiche mirate alla prevenzione della CIHL, e finalizzato alla stesura di raccomandazioni basate sull&#8217;evidenza\u00a0condivise a livello AIEOP ed in sinergia con simili iniziative in corso in vari paesi europei.<\/span><\/p>\n<p><span style=\"font-family: verdana, sans-serif;\">Vi chiediamo di compilare la\u00a0<em>survey\u00a0<\/em>inserendo i vostri dati (email) tramite il link allegato (in caso di difficolt\u00e0 con il link \u00e8 possibile compilare il pdf ed inviarlo via email a segreteria AIEOP)\u00a0<u>entro l&#8217;11 aprile 2025.<\/u><\/span><br \/>\n<span style=\"font-family: verdana, sans-serif;\">I risultati preliminari di tale\u00a0<em>survey\u00a0<\/em>saranno presentati alle giornate AIEOP di Aprile 2025 ed, in modo definitivo, in occasione dei prossimi meeting scientifici nazionali.<\/span><br \/>\n<span style=\"font-family: verdana, sans-serif;\">Ringraziando anticipatamente per la Vostra preziosa collaborazione, porgiamo i pi\u00f9 cordiali saluti.<\/span><\/p>\n<p><span style=\"font-family: verdana, sans-serif;\">Enrico Opocher,\u00a0<\/span>a nome del GDL nuovi Farmaci<\/p>\n<p>Clicca sul seguente link:<\/p>\n<p><strong><a href=\"https:\/\/us17.mailchimp.com\/mctx\/clicks?url=https%3A%2F%2Fforms.gle%2FVkMhHRQDJKLZrvBk6&amp;xid=875fda42d6&amp;uid=85730897&amp;iid=4c81081a95&amp;pool=cts&amp;v=2&amp;c=1740475056&amp;h=904c97a9435e661f64c57ab240d31c16613e165524673edfb33aa1e9fe3d3cc9\" target=\"_blank\" rel=\"noopener\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/us17.mailchimp.com\/mctx\/clicks?url%3Dhttps%253A%252F%252Fforms.gle%252FVkMhHRQDJKLZrvBk6%26xid%3D875fda42d6%26uid%3D85730897%26iid%3D4c81081a95%26pool%3Dcts%26v%3D2%26c%3D1740475056%26h%3D904c97a9435e661f64c57ab240d31c16613e165524673edfb33aa1e9fe3d3cc9&amp;source=gmail&amp;ust=1741252703054000&amp;usg=AOvVaw2VyJ6DtAY7k3XzLBWDHFT0\">https:\/\/forms.gle\/<wbr \/>VkMhHRQDJKLZrvBk6<\/a><\/strong><\/p>\n<p>oppure in alternativa<\/p>\n<p><strong><a href=\"https:\/\/us17.mailchimp.com\/mctx\/clicks?url=https%3A%2F%2Fdocs.google.com%2Fforms%2Fd%2Fe%2F1FAIpQLSclcoz0Dm23GWS3RpckDo5mZ_Wq_DX4Tbh3PeMmFii5Ot2QFw%2Fviewform%3Fusp%3Dheader&amp;xid=875fda42d6&amp;uid=85730897&amp;iid=4c81081a95&amp;pool=cts&amp;v=2&amp;c=1740475056&amp;h=a149f6044fb88502a31160f7e1b8991d5dcac414fc4a0897aa30c79b9179649b\" target=\"_blank\" rel=\"noopener\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/us17.mailchimp.com\/mctx\/clicks?url%3Dhttps%253A%252F%252Fdocs.google.com%252Fforms%252Fd%252Fe%252F1FAIpQLSclcoz0Dm23GWS3RpckDo5mZ_Wq_DX4Tbh3PeMmFii5Ot2QFw%252Fviewform%253Fusp%253Dheader%26xid%3D875fda42d6%26uid%3D85730897%26iid%3D4c81081a95%26pool%3Dcts%26v%3D2%26c%3D1740475056%26h%3Da149f6044fb88502a31160f7e1b8991d5dcac414fc4a0897aa30c79b9179649b&amp;source=gmail&amp;ust=1741252703054000&amp;usg=AOvVaw1zFN4eVM_7hdKAbR_bxjOm\">https:\/\/docs.google.com\/forms\/<wbr \/>d\/e\/<wbr \/>1FAIpQLSclcoz0Dm23GWS3RpckDo5m<wbr \/>Z_Wq_DX4Tbh3PeMmFii5Ot2QFw\/<wbr \/>viewform?usp=header<\/a><\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-2\"><p><img decoding=\"async\" class=\"alignnone size-full wp-image-10910\" src=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2025\/03\/1740511512190.jpg\" alt=\"\" width=\"527\" height=\"183\" \/><\/p>\n<\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[],"class_list":["post-10909","post","type-post","status-publish","format-standard","hentry","category-in-evidenza"],"_links":{"self":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/posts\/10909","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/comments?post=10909"}],"version-history":[{"count":1,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/posts\/10909\/revisions"}],"predecessor-version":[{"id":10912,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/posts\/10909\/revisions\/10912"}],"wp:attachment":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/media?parent=10909"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/categories?post=10909"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/tags?post=10909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}